SpyGlass Pharma

SGP

24.0002.91% ( -0.720 )

Closed: Oct 16, 16:00:00 (EDT)

Current ValuationThe current P/E ratio is -14.32, above the reasonable range, cheaper than 4.79% of the time in the past 1 years, and the industry ranks 201/256, the industry Median -1.16.

-14.32xP/E

Stock price$24.00Earnings per share$-1.68

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

0295887116

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

0x20x40x60x80x100x

P/E ratio
Name/Symbol
TAKUSTakeda Pharmaceutical Company	-59.49x	154.05%	$62.14B
BAYRYUSBayer	-24.32x	--	$49.00B
BAYZFUSBayer Aktiengesellschaft	-24.24x	--	$48.83B
VTRSUSViatris	-52.17x	107.68%	$21.43B
ELANUSElanco Animal Health	-59.13x	129.36%	$11.77B
VREOFUSVIREO GROWTH INC	-127.38x	--	$8.55B
AXSMUSAxsome Therap	-42.95x	21.51%	$8.23B
CURLFUSCuraleaf Holdings, Inc.	-115.20x	--	$5.99B
BLTEUSBelite Bio	-56.17x	29.87%	$5.75B
RGCUSRegencell Bioscience	-406.05x	--	$4.75B
MANEUSVeraDermics	-43.59x	97.44%	$4.55B
DFTXUSDefinium Therapeutics	-12.19x	54.37%	$4.31B
EWTXUSEdgewise Therapeutics	-20.48x	207.38%	$4.04B
AMLXUSAmylyx Pharmaceuticals	-21.74x	1.76%	$3.31B
TARSUSTarsus Pharmaceuticals	-64.27x	201.10%	$2.99B
ELVNUSEnliven Therapeutics	-25.81x	6.75%	$2.73B
MBXUSMBX Biosciences	-22.91x	31.12%	$2.39B
BHCUSBausch Health	-2.15x	569.84%	$2.36B
PRGOUSPerrigo	-1.33x	100.10%	$2.31B
SUPNUSSupernus Pharma	-20.04x	66.18%	$2.20B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.